Related Experiment Videos
Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001)
1The University of Iowa College of Medicine, Iowa City, IA, USA. ronald-jones@jonesgr.com
Diagnostic Microbiology and Infectious Disease
|July 13, 2001
Summary
This study established new quality control (QC) minimum inhibitory concentration (MIC) ranges for cefditoren, improving accuracy for testing common respiratory infection pathogens like Streptococcus pneumoniae and Haemophilus influenzae.
Area of Science:
- Clinical Microbiology
- Antimicrobial Susceptibility Testing
- Pharmaceutical Sciences
Background:
- Cefditoren exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria, including pathogens responsible for community-acquired respiratory tract infections.
- Inconsistencies in quality control (QC) recommendations from the National Committee for Clinical Laboratory Standards (NCCLS) have raised questions about the accuracy of in vitro antimicrobial susceptibility testing.
- Previous studies proposed conflicting and broad minimum inhibitory concentration (MIC) dilution ranges for common QC organisms, necessitating further investigation.
Purpose of the Study:
- To re-evaluate and propose standardized MIC ranges for cefditoren using NCCLS guidelines.
- To address the inconsistencies in current QC recommendations for cefditoren susceptibility testing.
- To enhance the reliability of in vitro testing for cefditoren against key bacterial pathogens.
Main Methods:
- A multi-laboratory investigation employing a seven-laboratory M23-A2 design was conducted.
- NCCLS-recommended guidelines were utilized to determine MIC ranges for cefditoren.
- Standardized QC strains including Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Staphylococcus aureus were tested.
Main Results:
- Proposed QC range recommendations for cefditoren: Streptococcus pneumoniae ATCC 49619 (0.016-0.06 µg/mL), Haemophilus influenzae ATCC 49247 (0.06-0.25 µg/mL), Escherichia coli ATCC 25922 (0.12-1 µg/mL), and Staphylococcus aureus ATCC 29213 (0.25-1 µg/mL).
- The proposed ranges validate previous findings for E. coli and H. influenzae.
- A narrower three log(2) dilution range may be sufficient for S. aureus and S. pneumoniae QC.
Conclusions:
- The proposed MIC ranges provide a more accurate and reliable basis for cefditoren quality control.
- Standardized QC ranges will improve the consistency and accuracy of cefditoren susceptibility testing in clinical laboratories.
- These findings contribute to the accurate therapeutic use of cefditoren in treating respiratory tract infections.